Savill Corrine - Net Worth and Insider Trading
Savill Corrine Net Worth
The estimated net worth of Savill Corrine is at least $3 Million dollars as of 2024-11-05. Savill Corrine is the Chief Business Officer of Cullinan Therapeutics Inc and owns about 165,990 shares of Cullinan Therapeutics Inc (CGEM) stock worth over $3 Million. Details can be seen in Savill Corrine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Savill Corrine has not made any transactions after 2024-02-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Savill Corrine
Savill Corrine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Savill Corrine owns 1 companies in total, including Cullinan Therapeutics Inc (CGEM) .
Click here to see the complete history of Savill Corrine’s form 4 insider trades.
Insider Ownership Summary of Savill Corrine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2024-02-01 | Acting Chief Business Officer |
Savill Corrine Latest Holdings Summary
Savill Corrine currently owns a total of 1 stock. Savill Corrine owns 165,990 shares of Cullinan Therapeutics Inc (CGEM) as of February 1, 2024, with a value of $3 Million.
Latest Holdings of Savill Corrine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2024-02-01 | 165,990 | 15.73 | 2,611,023 |
Holding Weightings of Savill Corrine
Savill Corrine Form 4 Trading Tracker
According to the SEC Form 4 filings, Savill Corrine has made a total of 5 transactions in Cullinan Therapeutics Inc (CGEM) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Cullinan Therapeutics Inc is the sale of 40,000 shares on February 1, 2024, which brought Savill Corrine around $647,200.
Insider Trading History of Savill Corrine
- 1
Savill Corrine Trading Performance
Savill Corrine Ownership Network
Ownership Network List of Savill Corrine
Ownership Network Relation of Savill Corrine
Savill Corrine Owned Company Details
What does Cullinan Therapeutics Inc do?
Who are the key executives at Cullinan Therapeutics Inc?
Savill Corrine is the Acting Chief Business Officer of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include See Remarks Jennifer Michaelson , director & President and CEO Nadim Ahmed , and Chief Legal Officer Jacquelyn L Sumer .
Cullinan Therapeutics Inc (CGEM) Insider Trades Summary
Over the past 18 months, Savill Corrine made 3 insider transaction in Cullinan Therapeutics Inc (CGEM) with a net sale of 120,000. Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 94,903 shares made by Jennifer Michaelson , a net sale of 5,708 shares made by Jeffrey Trigilio , and a net sale of 3,027 shares made by Jeffrey Alan Jones .
In summary, during the past 3 months, insiders sold 8,000 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 8,000 shares. During the past 18 months, 231,648 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 231,648 shares.
Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cullinan Therapeutics Inc Insider Transactions
Savill Corrine Mailing Address
Above is the net worth, insider trading, and ownership report for Savill Corrine. You might contact Savill Corrine via mailing address: C/o Cullinan Oncology, Llc, One Main Street Suite 520, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
